BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 27, 2016
View Archived Issues
Pfizer discloses vanin-1 inhibitors
Read More
A-000830 is a promising novel small-molecule inhibitor of ecto-nucleotidase CD73
Read More
HTL-001 is highly cytotoxic to prostate and breast cancer cells in vitro and in vivo
Read More
Ono gains access to Ligand Pharmaceuticals' OmniAb platform
Read More
Bantam Pharmaceutical patents mRNA translation initiation inhibitors
Read More
Lead Pharma Cel Models and Sanofi disclose RORgamma modulators
Read More
GlaxoSmithKline and University of Dundee describe antiparasitic agents
Read More
Genticel and Genkyotex sign contribution agreement
Read More
First patient enrolled in LTX-315 anti-PD-1 combination study
Read More
RespireRx Pharmaceuticals announces positive results from phase IIb PACE study
Read More
RO-689921 is well tolerated in patients with solid tumors
Read More
Neothetics initiates phase II trial of LIPO-202 for the reduction of submental subcutaneous fat
Read More
Strongbridge Biopharma acquires U.S. rights to Keveyis from Taro
Read More
First patient enrolled in BioHaven's phase IIb/III study of BHV-4157
Read More
FDA grants approval to Spinraza for treatment of spinal muscular atrophy
Read More
FDA accepts betrixaban NDA for priority review, EMA validates MAA
Read More
Pluristem and NYBC to collaborate in developing PLX-R18 cell therapy
Read More
Tokai Pharmaceuticals and Otic Pharma enter definitive share purchase agreement
Read More
Biocartis announces RAS biomarker testing collaboration with Amgen in Europe
Read More
Phase IIb data support advancement of linaclotide colonic release-1 in IBS-C
Read More
Dipexium and PLx Pharma enter merger agreement
Read More
Synergy Pharmaceuticals reports topline results of second pivotal study of plecanatide in IBS-C
Read More
TiGenix submits responses to EMA regarding Cx-601 MAA
Read More
MSD seeks approval of additional indication for Keytruda in Japan
Read More